Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study.

C PatrunoMaddalena NapolitanoG ArgenzianoKetty PerisM OrtoncelliGiampiero GirolomoniA OffidaniS M FerrucciG F AmorusoM RossiLuca Stingeni Giovanna MalaraT GriecoC FotiM GattoniC LoiM IannoneM TalamontiG StincoF RongiolettiP D PigattoA CristaudoE NettisM CorazzaF GuarneriP AmerioM EspositoA Belloni FortinaC PotenzaG Fabbrocininull null

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)

Therapy with dupilumab led to a significant improvement of AD over a 16-week treatment period, with a good safety profile. Therefore, dupilumab could be considered as an efficacious and safe treatment for AD also in the elderly.

Keyphrases

atopic dermatitis
clinical trial
middle aged
randomized controlled trial
study protocol
bone marrow
cell therapy